Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
Psychedelics In Minnesota: Gov Walz Authorizes Task Force & Safe Consumption Sites Via Omnibus Health Bill
May 25, 2023
From Benzinga
Psychedelics In Colorado: Gov Ratifies Bill, Report Shows No Increase In Public Health Harms
May 25, 2023
From Benzinga
Novel DMT Compound For Anxiety Shows Clinical Progress: Robust Effects Within 2 Minutes
May 24, 2023
Tickers
CYBN
From Benzinga
Microdosing LSD For Major Depression Treatment Seeks Further Clinical Validation Via New Study
May 24, 2023
From Benzinga
From Benzinga
Psychedelics Reform Update: MI's Task Force, NC's $5M Fund, CA's Fed Follow-Up, ME Tables Proposal
May 23, 2023
From Benzinga
From Benzinga
Canadians Share Insights On Psychedelics: Survey Reveals Real-World Use And Access Trends
May 21, 2023
From Benzinga
This Biotech Company Discovers What May Be The First New Compounds Of Psilocybin In History
May 19, 2023
From Benzinga
MindMed's LSD Study For Anxiety Treatment Enrolls And Doses 100 Participants, More Expected
May 19, 2023
Tickers
MNMD
From Benzinga
PharmAla Biotech Nabs First-Ever Canadian Approval To Provide MDMA Treatment Outside Clinical Setting
May 18, 2023
From Benzinga
The Psychedelic Mushrooms Market; Between Legitimate Harvesting And Illegal Retail Sales
May 17, 2023
Tickers
OPTHF
From Benzinga
African Iboga Root Heads To Canadian Company Developing Natural Drugs To Help Treat Addictions
May 17, 2023
Tickers
FLHLF
From Benzinga
Seelos Therapeutics Positive Q1 Financials Make For 'The Most Important Year' In Company's History
May 16, 2023
Tickers
SEEL
From Benzinga
Psychedelic Therapies Soon Available In Australia Via Incannex Healthcare And Subsidiary
May 16, 2023
Tickers
IXHL
From Benzinga
Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More
May 15, 2023
From Benzinga
From Benzinga
From Benzinga
Psychedelics Reform Update: AZ Budget Includes Psilocybin Research, ME's Psilocybin Act & More
May 14, 2023
Tickers
DEA
From Benzinga
EXCLUSIVE: Lessons From Psychedelics Markets Through Business, Legal And Reciprocity Lenses
May 12, 2023
Tickers
BWVI
From Benzinga
Terran Biosciences' Four Patent Applications Cover Improved Versions Of Classic Empathogens
May 12, 2023
From Benzinga
EXCLUSIVE: Clearmind Medicine Secures Approval To Launch Clinical Trial For Alcohol Addiction Treatment
May 12, 2023
Tickers
CMND
From Benzinga
GH Research: Q1 2023 Financials And Businesses For European 5-MeO-DMT Depression Treatment Developer
May 11, 2023
Tickers
GHRS
From Benzinga
COMPASS Pathways Reports Q1 2023: Financials, Commercial Groundwork And Ongoing Phase 3 Trials
May 11, 2023
Tickers
CMPS
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.